Search Results

Synfini, Inc. announced that it has acquired rights to the patented Synfini® platform from SRI International®, and that it will operate as an independent firm.

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system designed to carry nucleotides to be developed as cancer treatments and vaccines, has entered into a research collaboration agreement with SRI, an independent nonprofit research institute based in Silicon Valley, California

SRI International, an independent nonprofit research institute behind countless cutting-edge technological advances, announced it will receive the Palo Alto Research Center, a Xerox company and technology pioneer.

Xerox Holdings Corporation announced the donation of the Palo Alto Research Center to SRI International, a nonprofit research institute behind some of the world’s most impactful deep tech advancements.

SRI International, an independent nonprofit research institute behind countless cutting-edge technological advances, announced the promotion of Kathlynn Brown to President of its Biosciences Division.

SRI International (SRI) today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer effective immediately.

Alira Health, a global advisory and clinical research firm, announced today its collaboration with the Scottsdale Research Institute (SRI) to provide comprehensive regulatory and clinical support with the goal to bring clinical research of psilocybin to the State of Arizona.